163 related articles for article (PubMed ID: 29236213)
1. Structural Probing, Screening and Structure-Based Drug Repositioning Insights into the Identification of Potential Cox-2 Inhibitors from Selective Coxibs.
Bommu UD; Konidala KK; Pamanji R; Yeguvapalli S
Interdiscip Sci; 2019 Jun; 11(2):153-169. PubMed ID: 29236213
[TBL] [Abstract][Full Text] [Related]
2. Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation.
Razzaghi-Asl N; Mirzayi S; Mahnam K; Sepehri S
J Mol Graph Model; 2018 Aug; 83():138-152. PubMed ID: 29936228
[TBL] [Abstract][Full Text] [Related]
3. Computational Structure-Based De Novo Design of Hypothetical Inhibitors against the Anti- Inflammatory Target COX-2.
Dhanjal JK; Sreenidhi AK; Bafna K; Katiyar SP; Goyal S; Grover A; Sundar D
PLoS One; 2015; 10(8):e0134691. PubMed ID: 26241744
[TBL] [Abstract][Full Text] [Related]
4. Molecular docking study and molecular dynamic simulation of human cyclooxygenase-2 (COX-2) with selected eutypoids.
Taidi L; Maurady A; Britel MR
J Biomol Struct Dyn; 2022 Feb; 40(3):1189-1204. PubMed ID: 32990169
[TBL] [Abstract][Full Text] [Related]
5. An Insilico evaluation of phytocompounds from Albizia amara and Phyla nodiflora as cyclooxygenase-2 enzyme inhibitors.
Loganathan Y; Jain M; Thiyagarajan S; Shanmuganathan S; Mariappan SK; Kizhakedathil MPJ; Saravanakumar T
Daru; 2021 Dec; 29(2):311-320. PubMed ID: 34415547
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a potent cyclooxygenase-2 inhibitor, S4, through docking-based pharmacophore screening, in vivo and in vitro estimations.
Tseng TS; Chuang SM; Hsiao NW; Chen YW; Lee YC; Lin CC; Huang C; Tsai KC
Mol Biosyst; 2016 Jul; 12(8):2541-51. PubMed ID: 27265567
[TBL] [Abstract][Full Text] [Related]
7. Exploring molecular docking with MM-GBSA and molecular dynamics simulation to predict potent inhibitors of cyclooxygenase (COX-2) enzyme from terpenoid-based active principles of
Nayak A; Gadnayak A; Dash KT; Jena S; Ray A; Nayak S; Sahoo A
J Biomol Struct Dyn; 2023 Dec; 41(20):10840-10850. PubMed ID: 36576262
[TBL] [Abstract][Full Text] [Related]
8. Molecular docking, molecular modeling, and molecular dynamics studies of azaisoflavone as dual COX-2 inhibitors and TP receptor antagonists.
Hadianawala M; Mahapatra AD; Yadav JK; Datta B
J Mol Model; 2018 Feb; 24(3):69. PubMed ID: 29480373
[TBL] [Abstract][Full Text] [Related]
9. Computer-aided identification of natural lead compounds as cyclooxygenase-2 inhibitors using virtual screening and molecular dynamic simulation.
Ounissi M; Kameli A; Tigrine C; Rachedi FZ
Comput Biol Chem; 2018 Dec; 77():1-16. PubMed ID: 30195234
[TBL] [Abstract][Full Text] [Related]
10. Deciphering the mechanism behind the varied binding activities of COXIBs through Molecular Dynamic Simulations, MM-PBSA binding energy calculations and per-residue energy decomposition studies.
Chaudhary N; Aparoy P
J Biomol Struct Dyn; 2017 Mar; 35(4):868-882. PubMed ID: 26982261
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel potential cyclooxygenase-2 inhibitors using ligand- and structure-based virtual screening approaches.
Cruz JV; Giuliatti S; Alves LB; Silva RC; Ferreira EFB; Kimani NM; Silva CHTP; Souza JSN; Espejo-Román JM; Santos CBR
J Biomol Struct Dyn; 2022 Aug; 40(12):5386-5408. PubMed ID: 33427075
[TBL] [Abstract][Full Text] [Related]
12. The bitter barricading of prostaglandin biosynthesis pathway: understanding the molecular mechanism of selective cyclooxygenase-2 inhibition by amarogentin, a secoiridoid glycoside from Swertia chirayita.
Shukla S; Bafna K; Sundar D; Thorat SS
PLoS One; 2014; 9(6):e90637. PubMed ID: 24603686
[TBL] [Abstract][Full Text] [Related]
13. Identification of new potential cyclooxygenase-2 inhibitors: insight from high throughput virtual screening of 18 million compounds combined with molecular dynamic simulation and quantum mechanics.
Heidarpoor Saremi L; Ebrahimi A; Lagzian M
J Biomol Struct Dyn; 2021 Mar; 39(5):1717-1734. PubMed ID: 32122267
[TBL] [Abstract][Full Text] [Related]
14. Discovery of new indomethacin-based analogs with potentially selective cyclooxygenase-2 inhibition and observed diminishing to PGE2 activities.
Kassab SE; Khedr MA; Ali HI; Abdalla MM
Eur J Med Chem; 2017 Dec; 141():306-321. PubMed ID: 29031075
[TBL] [Abstract][Full Text] [Related]
15. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
El-Sayed NA; Nour MS; Salem MA; Arafa RK
Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
[TBL] [Abstract][Full Text] [Related]
16. The study of dual COX-2/5-LOX inhibitors by using electronic-topological approach based on data on the ligand-receptor interactions.
Aksakal F; Shvets N; Dimoglo A
J Mol Graph Model; 2015 Jul; 60():79-88. PubMed ID: 26117823
[TBL] [Abstract][Full Text] [Related]
17. Studies of the benzopyran class of selective COX-2 inhibitors using 3D-QSAR and molecular docking.
Yadav DK; Saloni ; Sharma P; Misra S; Singh H; Mancera RL; Kim K; Jang C; Kim MH; Pérez-Sánchez H; Choi EH; Kumar S
Arch Pharm Res; 2018 Dec; 41(12):1178-1189. PubMed ID: 28822076
[TBL] [Abstract][Full Text] [Related]
18. New selective cyclooxygenase-2 inhibitors from cyclocoumarol: Synthesis, characterization, biological evaluation and molecular modeling.
Rayar AM; Lagarde N; Martin F; Blanchard F; Liagre B; Ferroud C; Zagury JF; Montes M; Sylla-Iyarreta Veitía M
Eur J Med Chem; 2018 Feb; 146():577-587. PubMed ID: 29407982
[TBL] [Abstract][Full Text] [Related]
19. Screening cyclooxygenase-2 inhibitors from Allium sativum L. compounds: in silico approach.
Sadeghi M; Miroliaei M; Fateminasab F; Moradi M
J Mol Model; 2021 Dec; 28(1):24. PubMed ID: 34970708
[TBL] [Abstract][Full Text] [Related]
20. Surface plasmon resonance studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agent.
Somvanshi RK; Kumar A; Kant S; Gupta D; Singh SB; Das U; Srinivasan A; Singh TP; Dey S
Biochem Biophys Res Commun; 2007 Sep; 361(1):37-42. PubMed ID: 17640617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]